Hemorrhagic Fever Claims 3 Lives in Western India
January 19, 2011
AHMADABAD, India (AP) -- An Ebola-like hemorrhagic fever has killed three people in western India and dozens of doctors will screen a community of about 16,000 people in efforts to contain the disease, a state health minister said Wednesday.
A woman died of the insect-transmitted illness two weeks ago in the Gujarat state village of Kolat and a doctor and nurse who treated her later also contracted the illness and died, state Health Minister Jay Narayan Vyas said.
India's National Institute of Virology later confirmed that the three died of Crimean-Congo Hemorrhagic Fever, an Ebola-like disease where patients can bleed to death if not treated quickly. The illness mainly affects animals, but ticks that live on sheep and cattle can pass the virus to people, who can transmit it through their blood or saliva.
The government has appointed 38 medical teams - each including doctors and veterinarians -- to screen all 16,000 residents in the area of Kolat, near the state's commercial capital of Ahmadabad.
Doctors and nurses in the region have been warned to take utmost precautions when treating patients showing symptoms of the deadly fever, Vyas said.
"The Gujarat government has launched an all-out campaign," Vyas said.
The woman's husband and brother-in-law also were critically ill with the fever and were being treated in a government hospital in Ahmadabad, he said.
A.C. Mishra, director of the virology institute, said the Gujarat government has moved quickly against the illness.
"It's a high-risk disease, but there's no need for panic yet," Mishra said.
Copyright 2011 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
http://www.intelihealth.com/IH/ihtIH/WSIHW000/333/7228/1387502.html
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment